HARROW, INC. — Director's Dealing 2008

Nov 25, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRANSDEL PHARMACEUTICALS INC (TDLP.OB)
CIK: 0001360214
Period of Report: 2008-11-21

Reporting Person: THORNLEY ANTHONY S (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-11-21	Stock Option (right to buy)	$0.70	A	80000	Acquired	2018-11-21	Common Stock (80000)	Direct

Footnotes

F1: The option vests and becomes exercisable in accordance with the following vesting schedule: one twentieth (1/20) of the
total shares granted shall vest each quarter, commencing on the first full quarter following the initial grant date of
November 21, 2008.